Stocktoria
PRECIGEN, INC. PGEN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-08-08
PRECIGEN, INC. statistics & valuation
Market cap$2.1B
P / B99.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -1141.1% | -3440.2% | -1602.5% | — | — |
| Net margin | -2588.2% | -3216.2% | -1540.6% | 105.2% | -646.0% |
| FCF margin | -927.6% | -1955.6% | -1099.9% | -260.0% | -441.7% |
| Return on assets | -161.2% | -86.9% | -63.5% | 13.1% | -25.6% |
| Return on equity | -1198.6% | -327.8% | -80.9% | 22.4% | -85.9% |
| Debt / equity | 4.46× | 0.00× | — | 0.34× | 1.68× |
| Current ratio | 3.09 | 4.76 | 2.99 | 1.50 | 4.52 |
| Revenue growth | 146.7% | -36.9% | -76.9% | 88.6% | -55.4% |
Source: SEC EDGAR filings · CIK 0001356090 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.